19.6.2017
•
News
Disputes
Agrofert Wins Final Decision in Dispute with United Bakeries
United Bakeries Group, which sells bakery products under the “Delta” and “Odkolek” brands, lost final decision in dispute with KŠB client Agrofert.
United Bakeries was ordered to return a CZK 100 million advance payment to Agrofert for a thwarted merger with Agrofert Group company Penam, which - according to the court - United Bakeries wrongly charged as a contractual penalty. Moreover, United Bakeries must pay default interest of CZK 36,000,000, plus the costs of the court proceedings.
The High Court in Prague thus upheld last May’s verdict by the Municipal Court in Prague, in which the court held that Agrofert was not responsible for the failed merger. The dispute began in 2011.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
